Cargando…
Association Between Plasma Trimethyllysine and Prognosis of Patients With Ischemic Stroke
BACKGROUND: Trimethyllysine, a trimethylamine N‐oxide precursor, has been identified as an independent cardiovascular risk factor in acute coronary syndrome. However, limited data are available to examine the role of trimethyllysine in the population with stroke. We aimed to examine the relationship...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9075360/ https://www.ncbi.nlm.nih.gov/pubmed/34816729 http://dx.doi.org/10.1161/JAHA.121.020979 |
_version_ | 1784701665146830848 |
---|---|
author | Xu, Jie Zhao, Mingming Wang, Anxin Xue, Jing Cheng, Si Cheng, Aichun Gao, Jianing Zhang, Qi Zhan, Rui Meng, Xia Xu, Ming Li, Hao Zheng, Lemin Wang, Yongjun |
author_facet | Xu, Jie Zhao, Mingming Wang, Anxin Xue, Jing Cheng, Si Cheng, Aichun Gao, Jianing Zhang, Qi Zhan, Rui Meng, Xia Xu, Ming Li, Hao Zheng, Lemin Wang, Yongjun |
author_sort | Xu, Jie |
collection | PubMed |
description | BACKGROUND: Trimethyllysine, a trimethylamine N‐oxide precursor, has been identified as an independent cardiovascular risk factor in acute coronary syndrome. However, limited data are available to examine the role of trimethyllysine in the population with stroke. We aimed to examine the relationship between plasma trimethyllysine levels and stroke outcomes in patients presenting with ischemic stroke or transient ischemic attack. METHODS AND RESULTS: Data of 10 027 patients with ischemic stroke/transient ischemic attack from the CNSR‐III (Third China National Stroke Registry) and 1‐year follow‐up data for stroke outcomes were analyzed. Plasma levels of trimethyllysine were measured with mass spectrometry. The association between trimethyllysine and stroke outcomes was analyzed using Cox regression models. Mediation analysis was performed to examine the mediation effects of risk factors on the associations of trimethyllysine and stroke outcomes. Elevated trimethyllysine levels were associated with increased risk of cardiovascular death (quartile 4 versus quartile 1: adjusted hazard ratio [HR], 1.72; 95% CI, 1.03–2.86) and all‐cause mortality (quartile 4 versus quartile 1: HR, 1.97; 95% CI, 1.40–2.78) in multivariate Cox regression model. However, no associations were found between trimethyllysine and nonfatal stroke recurrence or nonfatal myocardial infarction. Trimethyllysine was associated with cardiovascular death independent of trimethylamine N‐oxide. Both estimated glomerular filtration rate and hs‐CRP (high‐sensitivity C‐reactive protein) had significant mediation effects on the association of trimethyllysine with cardiovascular death, with a mediation effect of 37.8% and 13.4%, respectively. CONCLUSIONS: Elevated trimethyllysine level is associated with cardiovascular death among patients with ischemic stroke/transient ischemic attack. Mediation analyses propose that trimethyllysine contributes to cardiovascular death through inflammation and renal function, suggesting a possible pathomechanistic link. |
format | Online Article Text |
id | pubmed-9075360 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-90753602022-05-10 Association Between Plasma Trimethyllysine and Prognosis of Patients With Ischemic Stroke Xu, Jie Zhao, Mingming Wang, Anxin Xue, Jing Cheng, Si Cheng, Aichun Gao, Jianing Zhang, Qi Zhan, Rui Meng, Xia Xu, Ming Li, Hao Zheng, Lemin Wang, Yongjun J Am Heart Assoc Original Research BACKGROUND: Trimethyllysine, a trimethylamine N‐oxide precursor, has been identified as an independent cardiovascular risk factor in acute coronary syndrome. However, limited data are available to examine the role of trimethyllysine in the population with stroke. We aimed to examine the relationship between plasma trimethyllysine levels and stroke outcomes in patients presenting with ischemic stroke or transient ischemic attack. METHODS AND RESULTS: Data of 10 027 patients with ischemic stroke/transient ischemic attack from the CNSR‐III (Third China National Stroke Registry) and 1‐year follow‐up data for stroke outcomes were analyzed. Plasma levels of trimethyllysine were measured with mass spectrometry. The association between trimethyllysine and stroke outcomes was analyzed using Cox regression models. Mediation analysis was performed to examine the mediation effects of risk factors on the associations of trimethyllysine and stroke outcomes. Elevated trimethyllysine levels were associated with increased risk of cardiovascular death (quartile 4 versus quartile 1: adjusted hazard ratio [HR], 1.72; 95% CI, 1.03–2.86) and all‐cause mortality (quartile 4 versus quartile 1: HR, 1.97; 95% CI, 1.40–2.78) in multivariate Cox regression model. However, no associations were found between trimethyllysine and nonfatal stroke recurrence or nonfatal myocardial infarction. Trimethyllysine was associated with cardiovascular death independent of trimethylamine N‐oxide. Both estimated glomerular filtration rate and hs‐CRP (high‐sensitivity C‐reactive protein) had significant mediation effects on the association of trimethyllysine with cardiovascular death, with a mediation effect of 37.8% and 13.4%, respectively. CONCLUSIONS: Elevated trimethyllysine level is associated with cardiovascular death among patients with ischemic stroke/transient ischemic attack. Mediation analyses propose that trimethyllysine contributes to cardiovascular death through inflammation and renal function, suggesting a possible pathomechanistic link. John Wiley and Sons Inc. 2021-11-24 /pmc/articles/PMC9075360/ /pubmed/34816729 http://dx.doi.org/10.1161/JAHA.121.020979 Text en © 2021 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | Original Research Xu, Jie Zhao, Mingming Wang, Anxin Xue, Jing Cheng, Si Cheng, Aichun Gao, Jianing Zhang, Qi Zhan, Rui Meng, Xia Xu, Ming Li, Hao Zheng, Lemin Wang, Yongjun Association Between Plasma Trimethyllysine and Prognosis of Patients With Ischemic Stroke |
title | Association Between Plasma Trimethyllysine and Prognosis of Patients With Ischemic Stroke |
title_full | Association Between Plasma Trimethyllysine and Prognosis of Patients With Ischemic Stroke |
title_fullStr | Association Between Plasma Trimethyllysine and Prognosis of Patients With Ischemic Stroke |
title_full_unstemmed | Association Between Plasma Trimethyllysine and Prognosis of Patients With Ischemic Stroke |
title_short | Association Between Plasma Trimethyllysine and Prognosis of Patients With Ischemic Stroke |
title_sort | association between plasma trimethyllysine and prognosis of patients with ischemic stroke |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9075360/ https://www.ncbi.nlm.nih.gov/pubmed/34816729 http://dx.doi.org/10.1161/JAHA.121.020979 |
work_keys_str_mv | AT xujie associationbetweenplasmatrimethyllysineandprognosisofpatientswithischemicstroke AT zhaomingming associationbetweenplasmatrimethyllysineandprognosisofpatientswithischemicstroke AT wanganxin associationbetweenplasmatrimethyllysineandprognosisofpatientswithischemicstroke AT xuejing associationbetweenplasmatrimethyllysineandprognosisofpatientswithischemicstroke AT chengsi associationbetweenplasmatrimethyllysineandprognosisofpatientswithischemicstroke AT chengaichun associationbetweenplasmatrimethyllysineandprognosisofpatientswithischemicstroke AT gaojianing associationbetweenplasmatrimethyllysineandprognosisofpatientswithischemicstroke AT zhangqi associationbetweenplasmatrimethyllysineandprognosisofpatientswithischemicstroke AT zhanrui associationbetweenplasmatrimethyllysineandprognosisofpatientswithischemicstroke AT mengxia associationbetweenplasmatrimethyllysineandprognosisofpatientswithischemicstroke AT xuming associationbetweenplasmatrimethyllysineandprognosisofpatientswithischemicstroke AT lihao associationbetweenplasmatrimethyllysineandprognosisofpatientswithischemicstroke AT zhenglemin associationbetweenplasmatrimethyllysineandprognosisofpatientswithischemicstroke AT wangyongjun associationbetweenplasmatrimethyllysineandprognosisofpatientswithischemicstroke |